Neuchâtel, Switzerland

Eleni Daskalaki

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitât Bern. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eleni Daskalaki: Innovator in Insulin Delivery Systems

Introduction

Eleni Daskalaki is a prominent inventor based in Neuchâtel, Switzerland. She has made significant contributions to the field of medical technology, particularly in the area of insulin delivery systems. Her innovative approach combines advanced algorithms with personalized medicine to improve diabetes management.

Latest Patents

Eleni Daskalaki holds a patent for her invention titled "Estimation of insulin based on reinforcement learning." This patent focuses on determining the optimal insulin to be delivered by an insulin infusion pump. The method utilizes a reinforcement learning algorithm aimed at personalized glucose regulation. The algorithm optimizes the daily basal insulin rate and insulin-to-carbohydrate ratio for each patient based on their measured glucose profile. This innovative approach allows for real-time learning of patient-specific characteristics, providing individualized insulin treatment. An automatic and personalized tuning method enhances the algorithm's performance.

Career Highlights

Eleni Daskalaki is affiliated with the University of Bern, where she continues her research and development in medical technology. Her work has garnered attention for its potential to revolutionize diabetes care through personalized treatment options.

Collaborations

Eleni collaborates with notable colleagues, including Peter Diem and Stavroula Mougiakakou, who contribute to her research efforts and advancements in the field.

Conclusion

Eleni Daskalaki's innovative work in insulin delivery systems exemplifies the intersection of technology and healthcare. Her contributions are paving the way for more effective diabetes management solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…